Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Q3 2022 Amedisys Inc Earnings Call Transcript

Oct 27, 2022 / 03:00PM GMT
Release Date Price: €103 (+3.00%)
Operator

Greetings. Welcome to the Amedisys Third Quarter 2022 Earnings Call. (Operator Instructions) Please note that today's conference is being recorded.

At this time, I'll turn the conference over to Nick Muscato, Chief Strategy Officer. Nick, you may now begin. And Nick, please go ahead. Mr. Muscato, you may begin your presentation.

(technical Difficulties]

Nick Muscato
Amedisys, Inc. - Chief Strategy Officer

Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of our third quarter ended September 30, 2022. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on the Investor Relations page on our website.

Speaking on today's call from Amedisys will be President and Chief Executive Officer, Chris Gerard; and Executive Vice President and Chief Financial Officer, Scott Ginn.

Before we get started with our call, I would like to remind everyone that statements made on this conference call today may constitute forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot